NDC properties for "Retacrit" (RxCUI 2463737)
About this data
The tables show NDC propoerties for Retacrit with the RxCUI 2463737
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Retacrit (RxCUI 2463737)
| BLA | BLA125545 |
|---|---|
| MMSL_CODE | BD37280 |
| RxCUI | 2463737 |
| SPL_SET_ID | 3af26b0d-8ad0-44e1-a538-8bdb5ab39374 |
| SPL_SET_ID | e6e4dd0c-25ca-40b2-ba6b-6138a68621fe |
| Prescribable Synonym | Retacrit 20,000 UNT/ML Injectable Solution |
| RXNAV_STR | Retacrit 20000 UNT/ML Injectable Solution |
| RxNorm Name | epoetin alfa-epbx 20000 UNT/ML Injectable Solution [Retacrit] |
| RxNorm Synonym | EPO-epbx 20000 UNT/ML Injectable Solution [Retacrit] |
| RxNorm Synonym | ERYTHROPOIETIN-epbx 20000 UNT/ML Injectable Solution [Retacrit] |
| RxNorm Synonym | Retacrit 20000 UNT/ML Injectable Solution |
| Related queries | Interactions (for RxCUI 2463737) |
NDC Properties
NDC Item 00069131101
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-01 |
| NDC Item | 00069131101 |
| Packaging | 1 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 00069131104
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-04 |
| NDC Item | 00069131104 |
| Packaging | 4 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-04) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 00069131110
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-10 |
| NDC Item | 00069131110 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-10) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 59353012001
| NDC 9 | 59353-120 |
|---|---|
| NDC 10 | 59353-120-01 |
| NDC Item | 59353012001 |
| Packaging | 1 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-120 |
NDC Item 59353012010
| NDC 9 | 59353-120 |
|---|---|
| NDC 10 | 59353-120-10 |
| NDC Item | 59353012010 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (59353-120-10) / 1 mL in 1 VIAL, MULTI-DOSE (59353-120-01) |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-120 |
NDC Item 00069131101
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-01 |
| NDC Item | 00069131101 |
| Packaging | 1 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 00069131104
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-04 |
| NDC Item | 00069131104 |
| Packaging | 4 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-04) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 00069131110
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-10 |
| NDC Item | 00069131110 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-10) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 59353012001
| NDC 9 | 59353-120 |
|---|---|
| NDC 10 | 59353-120-01 |
| NDC Item | 59353012001 |
| Packaging | 1 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-120 |
NDC Item 59353012010
| NDC 9 | 59353-120 |
|---|---|
| NDC 10 | 59353-120-10 |
| NDC Item | 59353012010 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (59353-120-10) / 1 mL in 1 VIAL, MULTI-DOSE (59353-120-01) |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-120 |
NDC Item 00069131101
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-01 |
| NDC Item | 00069131101 |
| Packaging | 1 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 00069131104
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-04 |
| NDC Item | 00069131104 |
| Packaging | 4 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-04) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 00069131110
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-10 |
| NDC Item | 00069131110 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-10) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 59353012001
| NDC 9 | 59353-120 |
|---|---|
| NDC 10 | 59353-120-01 |
| NDC Item | 59353012001 |
| Packaging | 1 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-120 |
NDC Item 59353012010
| NDC 9 | 59353-120 |
|---|---|
| NDC 10 | 59353-120-10 |
| NDC Item | 59353012010 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (59353-120-10) / 1 mL in 1 VIAL, MULTI-DOSE (59353-120-01) |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-120 |
NDC Item 00069131101
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-01 |
| NDC Item | 00069131101 |
| Packaging | 1 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 00069131104
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-04 |
| NDC Item | 00069131104 |
| Packaging | 4 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-04) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 00069131110
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-10 |
| NDC Item | 00069131110 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-10) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 59353012001
| NDC 9 | 59353-120 |
|---|---|
| NDC 10 | 59353-120-01 |
| NDC Item | 59353012001 |
| Packaging | 1 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-120 |
NDC Item 59353012010
| NDC 9 | 59353-120 |
|---|---|
| NDC 10 | 59353-120-10 |
| NDC Item | 59353012010 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (59353-120-10) / 1 mL in 1 VIAL, MULTI-DOSE (59353-120-01) |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-120 |
NDC Item 00069131101
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-01 |
| NDC Item | 00069131101 |
| Packaging | 1 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 00069131104
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-04 |
| NDC Item | 00069131104 |
| Packaging | 4 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-04) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 00069131110
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-10 |
| NDC Item | 00069131110 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-10) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0069-1311 |
NDC Item 59353012001
| NDC 9 | 59353-120 |
|---|---|
| NDC 10 | 59353-120-01 |
| NDC Item | 59353012001 |
| Packaging | 1 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-120 |
NDC Item 59353012010
| NDC 9 | 59353-120 |
|---|---|
| NDC 10 | 59353-120-10 |
| NDC Item | 59353012010 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (59353-120-10) / 1 mL in 1 VIAL, MULTI-DOSE (59353-120-01) |
| BLA | BLA125545 |
| FDA SPL set id | 793734 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 59353-120 |